Clinical Trial Update: Placebo-Controlled, Single-Dose Challenge Study of Gaboxadol in Adult Males With Fragile X Syndrome (FXS) [Phase 2]

View source ↗

Summary

A Phase 2, placebo-controlled, single-dose trial of gaboxadol in adult males with Fragile X syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fragile Syndrome

Drugs mentioned

• Gaboxadol (gaboxadol)

Snippet

Sponsor: Craig Erickson | Conditions: Fragile X Syndrome | Phase 2 | Status: COMPLETED